Bioscience Stock Down News Today

Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Free Report) CEO James W. Green acquired 20,000 shares of the business’s stock in a transaction dated Thursday, June 6th. The stock was purchased at an average price of $3.07 per share, with a total value of $61,400.00. Following the acquisition, the chief executive officer now owns 3,101,091 shares […]

Twist Bioscience (NASDAQ:TWST – Free Report) had its target price lifted by Barclays from $30.00 to $45.00 in a report issued on Thursday morning, Benzinga reports. The firm currently has an overweight rating on the stock. Several other research firms have also recently weighed in on TWST. Berenberg Bank assumed coverage on shares of Twist […]

Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) shares rose 6% on Monday . The stock traded as high as $36.04 and last traded at $35.61. Approximately 153,214 shares traded hands during mid-day trading, a decline of 85% from the average daily volume of 1,037,175 shares. The stock had previously closed at $33.60. Analyst Ratings […]

Twist Bioscience Co. (NASDAQ:TWST – Get Free Report)’s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $34.40, but opened at $36.05. Twist Bioscience shares last traded at $34.42, with a volume of 59,591 shares trading hands. Wall Street Analyst Weigh In A number of equities research […]

Skye Bioscience, Inc. (OTCMKTS:SKYE – Get Free Report) was the recipient of a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 1,300 shares, an increase of 1,200.0% from the November 15th total of 100 shares. Based on an average daily volume of 7,400 shares, […]

Invenomic Capital Management LP raised its stake in Lexaria Bioscience Corp. (NASDAQ:LEXX – Free Report) by 62.0% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 766,573 shares of the company’s stock after buying an additional 293,470 shares during the quarter. Invenomic Capital Management LP owned approximately 9.48% […]

Baillie Gifford & Co. raised its position in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 17.6% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 1,269,926 shares of the company’s stock after acquiring an additional 189,896 shares during the period. Baillie Gifford & Co. owned approximately 2.22% […]

Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.92 and traded as low as $0.62. Daré Bioscience shares last traded at $0.63, with a volume of 280,238 shares trading hands. […]

Aadi Bioscience, Inc. (NASDAQ:AADI – Free Report) Chairman Neil Desai sold 16,171 shares of the stock in a transaction on Wednesday, July 5th. The stock was sold at an average price of $6.55, for a total transaction of $105,920.05. Following the sale, the chairman now owns 1,763,372 shares of the company’s stock, valued at $11,550,086.60. […]

Twist Bioscience Co. (NASDAQ:TWST – Free Report) has received an average recommendation of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among […]